Prostate Cancer | Tumor

CURE’s prostate cancer page is an extensive resource of cancer information featuring the latest prostate cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on prostate cancer.

Dear John Wayne: Let’s Cut ‘the Big C’ Down to Size, Because Cancer Is a Coward

May 2nd 2022

John Wayne coined the term, “the Big C,” for cancer, but I think it’s time that the capital letter C stands for something better.

10-Year-Old Child With Cancer Sworn in as Honorary Member of NYPD, Experts Suggest a New Name for Certain Prostate Cancers and More

April 22nd 2022

From Philadelphia Flyers’ employees suing the organization after developing a rare blood cancer to experts proposing a new name for low-risk prostate cancer and an actor on Disney+’s “The Mandolorian” dying of cancer, here’s what is happening in the cancer space this week.

Trial to Evaluate Safety, Efficacy of Novel Drug for Various Solid Tumors Treats First Patient

April 15th 2022

The primary focus of the trial is to evaluate the incidence of treatment-emergent and serious side effects in patients receiving either the novel drug alone or in combination with Keytruda.

Cancer Survivor to Run Boston Marathon Alongside His Organ Donor, HIV Drug Shows Promise in Treating Metastatic Colon Cancer and More

April 8th 2022

From liver cancer survivor planning to run the upcoming Boston Marathon with his organ donor to a common HIV drug showing promise in treating colorectal cancer, here’s what’s happening in the cancer space this week.

FDA’s Approval of Pluvicto Gives Some Patients With Prostate Cancer a ‘Truly Targeted Therapy’ With Modest Side Effects

March 28th 2022

A recently FDA-approved drug offers patients with metastatic castration-resistant prostate cancer a newer treatment that improves survival, but is not curative of the disease, which means that more research is needed, according to an expert.

FDA Approves First PSMA-Targeted Therapy for Metastatic Castration-Resistant Prostate Cancer

March 23rd 2022

Patients with PSMA-positive metastatic castration-resistant prostate cancer can now be treated with Pluvicto, which may provide hope to an unmet need in this patient population.

Actor William Hurt Dies of Prostate Cancer, Several Cancer Centers Establish Helpline to Connect Ukrainian Patients to Cancer Care and More

March 18th 2022

From two celebrity deaths due to cancer to leading American cancer organizations coming together to help patients with cancer fleeing Ukraine, here’s what’s happening in the cancer space this week.

Merck Stops Trial After Analysis Reveals Keytruda Plus Lynparza Was Ineffective in Prostate Cancer Treatment

March 16th 2022

In a news release, Merck advised patients enrolled on the trial to consult with their health care provider regarding their treatment.

Male Cancer Caregivers Navigate A Gauntlet of Challenges, Often Under The Cover of Darkness

March 15th 2022

Regardless of a man’s age, providing care to a partner or family member with cancer has been shown to take a drastic toll on their health. To make matters worse, research shows many men struggle in silence.

PSMA-Targeted Treatment Improves Bone-Related Pain in Metastatic, Castration-Resistant Prostate Cancer

March 7th 2022

Patients treated with Lutetium-177 PSMA-617 tended to experience improvements in quality of life related to the aches and pains that can come from bone metastases.

Even in the Prescence of Health Complications and Other Medications, Nubeqa Maintains Safety, Efficacy in Prostate Cancer Treatment

February 21st 2022

Patients with nonmetastatic castration-resistant prostate cancer who were taking other medications or had health complications still derived a survival benefit from treatment with Nubeqa, research showed.

Trial Launches to Assess Novel Immunotherapy Approach in Metastatic Prostate Cancer

February 1st 2022

A phase 1/2a clinical trial examining the effects of a treatment called LAVA-1207 for patients with metastatic prostate cancer has now begun.

Patients With Prostate Cancer May Experience Regret Years After Making Treatment Decision

January 31st 2022

One expert noted that patients with prostate cancer can take a few months to make an informed treatment decision without impacting their long-term outcomes.

Trial to Assess Dose Escalation of Experimental Drug Plus Immunotherapy in Solid Tumors Begins

January 18th 2022

The STELLAR-002 trial is currently underway to examine the combination of XL092, an experimental tyrosine kinase inhibitor, in combination with immuno-oncology therapies for patients with advanced solid tumors.

Partner-Inclusive Interventions May Help Recover Sexual Intimacy After Prostate Cancer

January 17th 2022

Prostate cancer survivors are encouraged to include their partners in interventions to improve sexual function after treatment — and, as study results show, it is better to have these conversations with providers sooner rather than later.

Online Sexual Health Support Program for Couples May Aid in Sexual Recovery After Prostate Cancer Treatment

January 11th 2022

Sexual dysfunction may often happen after prostate cancer treatment, and the results of one study shown that an online program for both the patient and their partner may help in this aspect of recovery.

Severe Incontinence After Radical Prostatectomy Improved Over the Last Decade, Although Advances Needed to Further Improve Outcomes

December 23rd 2021

Additional advancements in how radical prostatectomy is performed are needed to improve other urinary outcomes such as good urinary function and social incontinence.

Bayer Announces Combination Therapy With Nubeqa May Improve Survival in Metastatic Prostate Cancer Subset

December 3rd 2021

The pharmaceutical company announced preliminary results on a phase 3 trial, which demonstrated that Nubeqa with docetaxel and androgen deprivation therapy may improve overall survival in men with metastatic hormone-sensitive prostate cancer.

Active Surveillance Once Again the Preferred Option for Low-Risk Prostate Cancer

December 2nd 2021

With recently revised treatment guidelines, doctors may be more likely to recommend active surveillance to men with low-risk prostate cancer.

Men With Prostate Cancer After Surgery May Benefit From Shorter Duration of Radiation Therapy

November 15th 2021

Hypofractionated radiation for nearly five weeks in men with prostate cancer after surgery may have similar results without added side effects compared with radiation therapy for a standard duration of seven weeks.

I Had No Prostate Cancer Symptoms, or so I Thought

November 15th 2021

A man reflects on slight symptoms he was not concerned about leading up to his prostate cancer diagnosis.

Trial for Novel Advanced Prostate Cancer Drug Enrolls First Patient

October 11th 2021

The first patient was enrolled in a phase 2 clinical trial for the treatment of hormone-sensitive advanced prostate cancer.

Here’s How Men With Bladder, Colorectal and Prostate Cancer Can Treat Sexual Dysfunction

October 5th 2021

Treatments for bladder, colorectal and prostate cancer may cause sexual dysfunction in men. Here, an expert provides insight into how patients and survivors may improve their sexual health.

Here's Why Collaboration Is Important for Progress in Genitourinary Cancers

September 26th 2021

It is important that the whole community understand that basic research and clinical trials can continue to improve outcomes for patients with genitourinary cancer.

Inside the Shifting Treatment Landscape for Advanced Genitourinary Cancers

September 25th 2021

In this special issue of CURE®, we spoke with patients and health care providers about fertility issues, treatment advancements and other topics related to kidney, prostate, testicular and bladder cancers.

Age, Other Health Factors Can Play a Role in Cancer Treatment Decisions

September 23rd 2021

The prescription of systemic cancer therapies varies based on a patient’s age, comorbidities, cancer stage and other variables, according to recent research.

Lack of Smoking Data in Bladder, Kidney and Prostate Cancer Clinical Trials May Affect Patient Outcomes

September 17th 2021

Clinical trials that are designed to ask patients with bladder, kidney and prostate cancer about their smoking status may help patients better understand what to expect from their treatment based on their smoking habits.

Medicare Eligibility May Be Associated With More Cancer Diagnoses

September 16th 2021

The eligible age of 65 years for Medicare may be discouraging patients from getting screenings and tests as they wait for more health coverage.

The Importance of Active Surveillance in Low-Risk Prostate Cancer

September 15th 2021

Monitoring, rather than immediately treating, patients with low-risk prostate cancer may be a better approach, says an expert from UCSF Helen Diller Family Comprehensive Cancer Center.

A Smart Bomb for Prostate Cancer

September 13th 2021

After decades of research, scientists inch closer to FDA approval for PSMA-targeted treatments that show promise for patients with an advanced form of prostate cancer.

NEXT PAGE
PREVIOUS PAGE